ClinConnect ClinConnect Logo
Search / Trial NCT06816563

Prediction of Version Outcomes for External Maneuvers of Breech Fetus by Assessment of Breech Progression Angle

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Feb 4, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Breech Fetus

ClinConnect Summary

This clinical trial is studying a procedure called cephalic version, which is used to turn a baby that is in a breech position (feet or bottom first) into a head-down position before delivery. Breech presentations occur in about 3-4% of pregnancies at term and can increase the risks associated with delivery. The goal of the study is to explore if using a specific type of ultrasound can help predict whether this turning maneuver will be successful. By using this ultrasound, researchers hope to measure a specific angle that reflects how well the baby is positioned to descend during labor.

To participate in this trial, women must be over 18 years old and have a single pregnancy at term (between 37 and 42 weeks) with their baby in a breech position. However, certain conditions, like low amniotic fluid or previous uterine surgeries, may exclude someone from participating. Women who join the study can expect to undergo the ultrasound assessment as part of the evaluation process, helping to determine the best approach for their delivery. This research could provide valuable insights for improving outcomes for babies in breech presentations.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Women \>18 years of age with a single pregnancy at term (37-42 gestational weeks) with a fetus in breech presentation
  • Acquisition of Informed Consent Form
  • Exclusion Criteria:
  • Oligohydramnios: maximum flap \< 2cm
  • Placenta previa
  • Uterine malformations
  • Regular uterine dynamics
  • Metrorrhagia
  • Contraindications to vaginal delivery
  • Premature rupture of membranes
  • Nonreassuring cardiotocographic tracing
  • Previous uterine surgery

About Irccs Azienda Ospedaliero Universitaria Di Bologna

IRCCS Azienda Ospedaliero-Universitaria di Bologna is a prestigious research and healthcare institution in Italy, renowned for its commitment to advancing medical science and patient care through innovative clinical research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, facilitating the translation of laboratory findings into effective treatment strategies. The institution fosters a multidisciplinary approach, collaborating with various experts to conduct high-quality clinical trials aimed at improving health outcomes across a wide range of medical fields. With a strong emphasis on ethical standards and patient welfare, IRCCS Azienda Ospedaliero-Universitaria di Bologna plays a vital role in shaping the future of medicine through rigorous scientific inquiry and patient-centered care.

Locations

Bologna, , Italy

Bologna, , Italy

Patients applied

0 patients applied

Trial Officials

Aly Mohamed Alaaeldin Kamaleldin Aly Youssef, MD

Principal Investigator

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported